Shares of Fiserv plunged nearly 10% during trading hours after the company released its Q1 2026 results ahead of the market open, in a report that presented a mixed picture for investors focused on the business's underlying momentum.
On a headline basis, Fiserv delivered revenue of $5.03 billion, ahead of the consensus estimate of $4.73 billion, and non-GAAP adjusted earnings per share of $1.79, which topped estimates by 13.5%. Those beats, however, sat alongside weaker underlying metrics that appeared to unsettle the market.
Organic revenue fell 4% in Q1 2026 versus the prior year period, and adjusted EPS declined 16% year-over-year. The company reported a marked contraction in adjusted operating margin, which narrowed to 29.7% from 37.8% in Q1 2025. Free cash flow also retreated to $259 million from $371 million in the prior-year quarter.
Management acknowledged that the effects of the company’s transition are "not yet visible" in reported financial results. Executives said the firm is still comparing against prior-period nonrecurring revenue and is absorbing incremental investment spend, with the expectation that improved operating performance should become more apparent in the second half of 2026 and into 2027.
CEO Mike Lyons said the company is "focused on advancing the One Fiserv Action Plan," and noted that management looks "forward to providing more details on our strategy and medium-term financial outlook at our May 14 Investor Day." Those comments signal management’s intent to outline the plan behind the transition and to provide forward-looking context to investors at the mid-May event.
Analysts responded by cutting price targets even as they retained varied ratings. Morgan Stanley trimmed its target from $81 to $64 while keeping an "equal weight" stance. Susquehanna kept a "positive" view but reduced its target from $99 to $91. BNP Paribas Exane lowered its target from $64 to $63 and maintained a "neutral" designation. The wave of target reductions added to downward pressure on the stock.
Market conditions provided little excuse for Fiserv’s weakness. The broader U.S. equity gauge advanced on the day - the S&P 500 rose 0.89%, the Dow Jones Industrial Average increased 0.64%, and the NASDAQ climbed 1.09% - indicating that Fiserv’s decline was driven by company-specific developments rather than a general market selloff.
Despite repurchasing 3.3 million shares for $200 million during the quarter, the company’s cash-flow retreat and margin compression weighed on sentiment. After the results and analyst reactions, Fiserv shares traded at $56.67, approaching the 52-week low of $52.91 cited in the period surrounding the report.
Investors and market participants noted that while headline revenue and adjusted EPS outperformed consensus, the year-over-year declines in revenue and earnings, the substantial margin contraction, and the lack of a convincing near-term recovery in guidance left the market unconvinced. The reaffirmed guidance, with a midpoint that marginally cleared consensus, did not appear sufficient to offset concerns about organic growth deterioration and operating leverage.
Key takeaways
- Fiserv beat consensus on total revenue and non-GAAP EPS but reported a 4% decline in organic revenue and a 16% drop in adjusted EPS year-over-year.
- Adjusted operating margin compressed to 29.7% from 37.8% in Q1 2025, and free cash flow fell to $259 million from $371 million.
- Management said progress from its transition is "not yet visible" in reported results and plans to provide more details at the May 14 Investor Day; several analysts lowered price targets.
Impacted sectors
- Payments and financial technology companies, which face scrutiny over growth and margin recovery.
- U.S. equities, where company-specific earnings can drive individual stock moves even when broader indices advance.
Risks and uncertainties
- The company's transition-related improvements are not yet reflected in reported financials, creating timing risk for when operating performance will improve.
- Continued margin pressure and declining organic revenue could further erode earnings and investor confidence if the expected recovery in the second half of 2026 does not materialize.
- Analyst target cuts and investor reaction to reaffirmed guidance that only modestly exceeds consensus at the midpoint present near-term valuation and sentiment risks for the stock.